Expert Roundtables Podcast: The Use of Biomarkers in the Management of Endometrial Cancer – Expert Perspectives
expert roundtables by David Scott Miller, MD, FACOG, FACS; Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS; Pamela T. Soliman, MD, MPH When combined with histological characteristics, molecular biomarkers support a personalized treatment approach for endometrial cancer. Selecting treatments based on a patient’s biomarkers may help to not only maximize treatment benefits but also prevent treatment-related toxicities in patients whose endometrial cancer is unlikely to respond to the therapies. Our featured
